Physician profile
John Nedelcu
NPI 1457793432
$4,902.96
in general payments reported to CMS, 2019-2025
21 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $72.15 · 2021: $397 · 2022: $875 · 2023: $555 · 2024: $1,230 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,119.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $968.33 | 2019-2025 | Precision7, Total30, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $917.71 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $688.13 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $408.60 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $383.32 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $250.69 | 2019-2023 | |
| Rxsight INC | $178.95 | 2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Oyster Point Pharma, INC. | $176.34 | 2022-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $157.08 | 2019-2022 | |
| Glaukos Corporation | $139.68 | 2024 | Idose |
| Mallinckrodt Hospital Products INC. | $125.15 | 2022 | |
| Spark Therapeutics, INC. | $125.00 | 2022 | |
| Dompe US, INC. | $111.10 | 2022-2025 | Oxervate |
| Optos, INC. | $60.06 | 2019 | |
| Biotissue Holdings INC. | $51.21 | 2019-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $51.06 | 2025 | Clariti Contact Lens |
| Kala Pharmaceuticals, INC. | $40.41 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $18.33 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $16.82 | 2020 | |
| Aerie Pharmaceuticals, INC. | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nedelcu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.